InvestorQ : Is it worth buying the Sun Pharma stock now after its recent progress on COVID-19?
Priyanka N made post

Is it worth buying the Sun Pharma stock now after its recent progress on COVID-19?

Answer
user profile image
NISHA Nayak answered.
3 months ago


Sun Pharma has been riding the pharma wave in the last few weeks and has rallied sharply. In an interest development, Sun Pharma is testing a plant-derived drug, AQCH, for possible treatment of COVID-19. It is currently in mid-stage trials. AQCH is derived from tropical, cocculus hirsutus, which is used across Asia for its medicinal properties and is specifically suited to addressing tropical infections. The trials are expected to be completed across 12 centres across 210 patients by October this year. While the core purpose of ACQH is to treat dengue, it has shown strong antiviral effect and therefore it is being tested as treatment option for COVID-19. The pandemic has already killed 4 lakh patients across the world. Apart from Sun Pharma, Glenmark and Strides are also conducting similar trials.